AngioDynamics (ANGO) Financial Statements & Analysis

AngioDynamics (ANGO) Income Statement

AngioDynamics reported revenue of $320.17M in fiscal 2026 (fiscal year ended May 31, 2026), up 9.5% from $292.50M a year earlier. AngioDynamics posted a net loss of $36.74M, compared with a net loss of $33.99M a year earlier. Gross margin was 54.6% and operating margin -7.0%. In the most recent quarter, Q1 fiscal 2027 (ended Aug 31, 2026), revenue was $80.92M, up 6.9% from the same quarter a year earlier.

AngioDynamics Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

AngioDynamics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	May 2026	May 2025	May 2024	May 2023	May 2022	May 2021	May 2020	May 2019	May 2018	May 2017
Revenue & Gross Profit
Revenue	320.17	292.50	303.91	338.75	316.22	291.01	264.16	359.48	344.29	349.64
Cost of Revenue	145.28	134.79	149.22	164.51	150.49	134.22	113.89	114.63	117.80	125.84
Gross Profit	174.89	157.71	154.70	174.25	165.73	156.79	150.27	156.00	143.86	143.95
Operating Expenses
Research & Development	29.45	26.22	31.32	29.88	30.48	36.39	29.68	29.44	25.46	25.27
Selling, General & Administrative	157.09	145.23	144.18	144.25	134.01	117.22	116.51	116.13	108.54	110.23
Operating Expenses	197.22	197.66	347.13	225.43	194.20	192.07	317.37	165.40	158.03	155.13
Operating Income	-22.33	-39.95	-192.44	-51.18	-28.47	-35.28	-167.10	-9.40	-14.17	-11.18
Other Income/Expense
Interest Income	0.00	0.98	1.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.30	0.00	0.00	2.70	-0.69	-0.86	0.91	5.10	3.06	2.84
Other Income/Expense	-13.67	5.92	0.80	-3.26	-1.48	-0.77	-1.04	-5.31	-3.09	-3.12
Income
Income Before Tax	-36.30	-34.03	-191.64	-54.44	-29.95	-36.05	-168.14	-14.70	-17.26	-14.30
Income Tax Expense	0.44	-0.04	-7.29	-2.00	-3.40	-4.50	-1.35	-3.56	-11.04	-7.24
Net Income	-36.74	-33.99	-184.35	-52.44	-26.55	-31.55	-166.79	61.34	16.34	-7.05
Net Income - Continuous Operations	-36.74	-33.99	-184.35	-52.44	-26.55	-31.55	-166.79	61.34	16.34	-7.05
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-
EBITDA	0.63	1.74	-8.65	12.19	11.13	-9.37	-143.42	16.28	8.96	13.36
EBIT	-22.33	-23.57	-33.96	-19.31	-18.22	-35.28	-	-	-	-
Depreciation & Amortization	10.68	25.80	25.31	30.87	29.35	25.92	23.81	25.88	23.16	24.81
Earnings Per Share
Basic EPS	-1.00	-1.00	-5.00	-1.00	-1.00	-1.00	-4.00	2.00	-	-
Diluted EPS	-1.00	-1.00	-5.00	-1.00	-1.00	-1.00	-4.00	2.00	-	-
Basic Shares Outstanding	41.53	40.98	40.18	39.48	39.01	38.34	37.96	37.48	37.08	36.62
Diluted Shares Outstanding	41.53	40.98	40.18	39.48	39.01	38.34	37.96	37.48	37.54	36.96

Source: Company financial statements from annual and quarterly filings. Data as of Aug 31, 2026. Data sources and methodology

Frequently Asked Questions About AngioDynamics Financial Statements

What was AngioDynamics's revenue in fiscal 2026?

AngioDynamics reported revenue of $320.17M in fiscal 2026 (fiscal year ended May 31, 2026). That was up 9.5% from $292.50M a year earlier.

Is AngioDynamics profitable?

No. AngioDynamics reported a net loss of $36.74M in fiscal 2026. In fiscal 2025 it lost $33.99M.

What is AngioDynamics's operating margin?

AngioDynamics's operating income was −$22.33M on revenue of $320.17M in fiscal 2026, an operating margin of -7.0%, compared with -13.7% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition